V
54.68
-1.26 (-2.25%)
| Penutupan Terdahulu | 55.94 |
| Buka | 55.50 |
| Jumlah Dagangan | 562,270 |
| Purata Dagangan (3B) | 1,359,405 |
| Modal Pasaran | 7,939,877,888 |
| Harga / Buku (P/B) | 2.93 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| EPS Cair (TTM) | -3.99 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.72% |
| Nisbah Semasa (MRQ) | 17.70 |
| Aliran Tunai Operasi (OCF TTM) | -459.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -419.13 M |
| Pulangan Atas Aset (ROA TTM) | -14.53% |
| Pulangan Atas Ekuiti (ROE TTM) | -19.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Vaxcyte, Inc. | Menaik | Menurun |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.60 |
|
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.68% |
| % Dimiliki oleh Institusi | 117.40% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ra Capital Management, L.P. | 31 Dec 2025 | 10,724,599 |
| Kynam Capital Management, Lp | 31 Dec 2025 | 2,922,335 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 116.00 (Guggenheim, 112.14%) | Beli |
| Median | 102.50 (87.45%) | |
| Rendah | 89.00 (BTIG, 62.77%) | Beli |
| Purata | 102.50 (87.45%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 58.70 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 26 Feb 2026 | 89.00 (62.77%) | Beli | 60.00 |
| Guggenheim | 02 Feb 2026 | 116.00 (112.14%) | Beli | 57.40 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| COWAN ELVIA | - | 56.51 | -4,392 | -248,793 |
| WASSIL JIM | - | 58.24 | -7,395 | -430,685 |
| Jumlah Keseluruhan Kuantiti Bersih | -11,787 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -679,478 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 57.08 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| COWAN ELVIA | Pegawai | 17 Mar 2026 | Jual automatik (-) | 1,892 | 55.48 | 104,968 |
| COWAN ELVIA | Pegawai | 11 Mar 2026 | Jual automatik (-) | 2,500 | 57.53 | 143,825 |
| COWAN ELVIA | Pegawai | 11 Mar 2026 | Pelaksanaan pilihan | 2,500 | - | - |
| WASSIL JIM | Pegawai | 10 Mar 2026 | Jual automatik (-) | 7,395 | 58.24 | 430,685 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit |
| 02 Feb 2026 | Pengumuman | Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares |
| 29 Jan 2026 | Pengumuman | Vaxcyte Announces Pricing of $550 Million Public Offering |
| 29 Jan 2026 | Pengumuman | Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants |
| 22 Jan 2026 | Pengumuman | Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |